Jianjun Qiao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Ulcerative Colitis

Atopic Dermatitis

Top Venues

American journal of therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Bai, Wang Su, Hong Fang, Jianjun Qiao
Efficacy of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Real-World Practice in a Single Center. American journal of therapeutics 31 (3) (2024)
Qingmiao Sun, Juan Bai, Su Wang, Hong Fang, Jianjun Qiao
JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis. American journal of therapeutics 31 (4) (2024)
Qingmiao Sun, Juan Bai, Su Wang, Hong Fang, Jianjun Qiao
JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis. American journal of therapeutics 31 (4) (2024)
Juan Bai, Wang Su, Hong Fang, Jianjun Qiao
Efficacy of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Real-World Practice in a Single Center. American journal of therapeutics (2024)
Qingmiao Sun, Juan Bai, Su Wang, Hong Fang, Jianjun Qiao
JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis. American journal of therapeutics (2024)
Qingmiao Sun, Juan Bai, Su Wang, Hong Fang, Jianjun Qiao
JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis. American journal of therapeutics 31 (4) (2024)
Xinyue Zhong, Taoming Liu, Linwei Wei, Juan Bai, Hong Fang, Jianjun Qiao
Tofacitinib for the Treatment of Trachyonychia. American journal of therapeutics 31 (4) (2024)